Browse studies

Find your next paid study

27,300 recruiting studies available now

A Single-Arm, Open-label, Phase II Study Evaluating Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors - (POSTPONE)

This is a single-arm, open-label phase 2 study to evaluate the role of pacritinib for patients with metastatic castrate-resistant prostate cancer that have pro…

Prostate Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Medical College of WisconsinNCT07226713

Multicenter Study of Tau Imaging With the Use of [18F]MK-6240 Tracer in Individuals at Risk for and With Autosomal Dominant Alzheimer's Disease

The recent development of a PET tracer,\[18F\]MK-6240(an\[18F\]tau imaging agent,CerveauTechnologies)that has high affinity for the human phosphorylated tau de…

Alzheimer Disease

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Tammie L. S. Benzinger, MD, PhDNCT04104659

Observational

Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks

To use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementa…

Hypertension (HTN)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT05208450

Phase 2

A Phase II Study of (IGFBP-2) Vaccine to Prevent Progression After Serologic Detection of Recurrent Ovarian Cancer

This phase II trial studies how well giving the insulin-like growth factor binding protein 2 \[pUMVC3-hIGFBP-2 multi-epitope plasmid deoxyribonucleic acid (DNA…

Fallopian Tube CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of WashingtonNCT07495124

Phase 1

Pilot Study for the Use of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency: A Phase I Clinical Trial

Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma with Mismatch Repair Deficiency.

GlioblastomaMismatch Repair Deficiency

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Jennifer LeddonNCT07385846

Phase 3

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4

This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclistamab in c…

Multiple Myeloma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

European Myeloma Network B.V.NCT05243797

Observational

Omega-3 Fatty Acid Modulation of Brown Adipose Tissue for Arctic Resilience

This clinical trial will assess the whether fish oil supplementation can modulate brown fat activation, shivering, thermal comfort and skin blood flow during c…

Cold Exposure

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT05822141

Phase 1

Combination External Radiation and 177Lu-DOTATATE for Large Gastrointestinal Neuroendocrine Tumors: A Single Arm Pilot Clinical Trial

This phase I trial tests the safety and effectiveness of stereotactic body radiation therapy (SBRT) followed by 177Lu-DOTATATE peptide receptor radionuclide th…

Digestive System Neuroendocrine TumorUnresectable Digestive System Neuroendocrine NeoplasmUnresectable Digestive System Neuroendocrine Tumor G1+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Emory UniversityNCT07150546

Phase 1

Reducing Disparities in Access to Evidence-Based Services for ADHD Through Technology

This project aims to develop an adaptation of the Collaborative Life Skills Program (CLS) that will be supported by mHealth technology. CLS is an evidence-base…

Control ConditionIntervention Condition

Estimated

~$150 – $3,000

Actual pay is set by the research site.

San Diego State UniversityNCT06900673

Phase 4

Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency: the PERT-AP Trial

This study aims to evaluate if a 6-month course of pancrelipase (CREON) treatment improves symptoms of exocrine pancreatic insufficiency (EPI) after an attack …

Exocrine Pancreatic Insufficiency

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Ohio State UniversityNCT06477159

Phase 1

Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and…

WomenAgingMenopause

Estimated

~$500 – $7,500

Actual pay is set by the research site.

University of Missouri-ColumbiaNCT07674680

Observational

Multimodal Investigation of Neural Plasticity Induced by Non-invasive Brain Stimulation

This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in cognitively intact older adults (healthy co…

Mild Cognitive Impairment

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT06453980